Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Cash Flows from Operating Activities
Net income	$ 7,951,803	$ 738,933
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization	5,003,751	4,778,933
Change in fair value of commodity derivative instruments	(132,392)	(113,708)
Gain on sale of asset	(45,000)
Change in operating assets and liabilities
Restricted cash	(178,766)	(630,941)
Commodity derivative instruments	1,011,695	822,194
Accounts receivable	6,045,360	7,767,738
Inventory	4,349,230	479,699
Prepaid expenses and other current assets	(258,875)	(194,517)
Accounts payable	(6,234,042)	(830,857)
Accrued expenses	448,356	323,107
Net Cash Provided by Operating Activities	17,961,120	13,140,581
Cash Flows from Investing Activities
Payment for investment deposit	(750,000)
Payments for capital expenditures	(769,790)	(2,611,556)
Proceeds from sale of assets	45,000
Net Cash Used in Investing Activities	(1,474,790)	(2,611,556)
Cash Flows from Financing Activities
Proceeds from long-term debt		7,611,180
Payments on long-term debt	(157,893)	(7,786,568)
Proceeds (payments) from checks drawn in excess of bank balance	(1,866,683)	(838,449)
Purchase of subsidiary units attributable to non-controlling interest	(46,644)
Distributions to non-controlling interests		(2,006,558)
Member distributions paid	(11,171,190)	(9,640,887)
Net Cash Used in Financing Activities	(13,242,410)	(12,661,282)
Net Decrease in Cash	3,243,920	(2,132,257)
Cash - Beginning of Period	13,797,857	12,696,536
Cash - End of Period	17,041,777	10,564,279
Cash paid during the period for:
Interest Expense	75,607	180,642
Supplemental Disclosure of Noncash Investing, Operating and Financing Activities
Capital expenditures and construction in process included in accounts payable	$ 187,500	$ 881,703